Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Alexza inhaled drug effective in study
The primary aim of the clinical trial was to assess the safety and efficacy of a single dose of AZ-004 in acutely treating agitation in schizophrenic patients. In
The primary aim of the clinical trial was to assess the safety and efficacy of a single dose of AZ-004 in acutely treating agitation in schizophrenic patients. In
As part of a previous agreement, Novartis had produced the multiple sclerosis drug for Bayer. Bayer will now manufacture Betaseron at the site in California and retain full
The study, using ultrasound technology, found that as well as lowering cholesterol Crestor is also effective at halting early changes in the blood vessels that can lead to
The recommendation is based on data from the phase III study which showed that the addition of Herceptin to hormonal therapy doubles the median progression-free survival, from 2.4
Lilly said the new facility would be known as the Lilly-Singapore Center for Drug Discovery and it aims to identify two potential drug candidates from its Singapore center
Under the agreement, EvoGenix utilized its protein optimization technology, EvoGene, to develop improved versions of a protein product from the GSK pharmaceutical pipeline. The protein variants generated had
The phase II trial was designed to assess the long-term safety and outcomes at six months of once or twice weekly infusions of Natrecor compared to placebo in
Patients with high cholesterol were treated for ten weeks with 400 mg/week of the drug ISIS 301012. In this study, increasing the dose of ISIS 301012 to 400
The study examined the thrombin receptor antagonist (TRA), SCH 530348, in combination with standard antiplatelet therapy (including aspirin and clopidogrel) among patients undergoing percutaneous coronary intervention (PCI). The
The decision came after a court ruled the Norvasc patent to be invalid. Pfizer said it would make the generic amlodipine besylate product immediately through the company’s Greenstone